- Report
- February 2025
- 182 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- February 2025
- 182 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- November 2024
- 145 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Report
- April 2025
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2731EUR$3,000USD£2,319GBP
- Drug Pipelines
- April 2025
- 100 Pages
Global
From €2731EUR$3,000USD£2,319GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1138EUR$1,250USD£966GBP
- Report
- January 2025
- 176 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Clinical Trials
- December 2024
- 280 Pages
Global
From €4551EUR$5,000USD£3,865GBP
- Report
- December 2024
- 30 Pages
Global
From €2958EUR$3,250USD£2,512GBP

The Immunoglobulin market is a segment of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Immunoglobulin (Ig) is a type of protein found in the blood that helps fight infection and disease. It is used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and infections. Immunoglobulin therapies are typically administered intravenously or subcutaneously, and can be used to replace or supplement the body's natural Ig production.
The Immunoglobulin market is highly competitive, with a number of companies offering a range of products. These products vary in terms of dosage, delivery method, and cost. Companies in the market are focused on developing new therapies and improving existing ones, as well as expanding their product portfolios.
Some of the major companies in the Immunoglobulin market include CSL Behring, Grifols, Kedrion, Octapharma, and Shire. Show Less Read more